Markets & Regulations

No more PURE water

No more PURE water

PURE Biosciences of the USA has opted to sell off its water
treatment business, which includes the Fillmaster line used in the
pharmaceutical industry, in order to focus on its
environmentally-friendly antimicrobial products.

BI wins antibody contract

BI wins antibody contract

German biotechnology company TeGenero has signed up Boehringer
Ingelheim to make clinical trials of its antibody drug in a move
that reflects an emerging trend in the contract manufacturing
sector.

Tough times at CyBio

Tough times at CyBio

Germany's CyBio, which makes laboratory instruments and equipment,
has seen its revenues in the first nine months of the year fall by
a third and expects to post a full-year loss.

Organon looks East

Organon looks East

Dutch company Organon has upgraded its manufacturing facilities in
China in a move that will for the first time allow it to create
pharmaceuticals for local consumption.

Solid 3Q showing at Evotec

Solid 3Q showing at Evotec

Evotec OAI once again defied the difficult environment for drug
discovery technology companies with a 20 per cent hike in
nine-month revenues to €56.7 million. Growth was driven by the
firm's ultra high-throughput screening collaboration...

Expansion for Ultrafine

Expansion for Ultrafine

Ultrafine has started construction of an additional facility to
expand its capabilities in the custom manufacturing of active
pharmaceutical ingredients (APIs) and intermediates.

Follow us

Products

View more

Webinars